The COVID-19 pandemic has disproportionately affected more vulnerable populations, including those living with dementia. Over 50 million individuals worldwide are living with Alzheimer's disease (AD) or other dementia, and it is crucial to continue the fight against the condition during the global pandemic. Since the start of mandated lockdowns in March 2020, charity and non-profit organizations that fund AD and related dementia research continue to respond to the needs of the AD research community, ensuring the momentum continues and accelerates. Members of the International Alzheimer's and Related Dementia Research Funder Consortium, a group of nearly 40 funding organizations that informally convene throughout the year to share updates and information, have taken a number of steps to ensure the continued support of the research community. Even during times of uncertainty, it is essential that the field moves forward to uncover preventions, diagnoses, and treatments for these diseases that affect many millions globally.

Alzheimer Forschung Initiative Düsseldorf Germany

Alzheimer's Disease International London UK

Alzheimer's Drug Discovery Foundation New York New York USA

Alzheimer's Research UK Cambridge UK

Alzheimer's Society UK London UK

BrightFocus Foundation Clarksburg Maryland USA

Czech Alzheimer Foundation Prague Czech Republic

Fondation Alzheimer Paris France

Fondation Vaincre Alzheimer Paris France

Medical and Scientific Relations Alzheimer's Association Chicago Illinois USA

Memory Clinic Department of Neurology Charles University 2nd Faculty of Medicine and Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Prince MJ, Wimo A, Guerchet M, et al. World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer's Disease International; 2015.

Suárez‐González A, Livingston G, Low LF, et al. Impact and mortality of COVID‐19 on people living with dementia: cross‐country report. LTCcovid.org, international long‐term care policy network. CPEC‐LSE. 2020.

Worst Hit: Dementia During Coronavirus. UK: Alzheimer's Society UK; 2020. https://www.alzheimers.org.uk/sites/default/files/2020‐09/Worst‐hit‐Dementia‐during‐coronavirus‐report.pdf

Tuttle KR. Impact of the COVID‐19 pandemic on clinical research. Nat Rev Nephrol. 2020;16(10):562‐564. PubMed PMC

Webster P. How is biomedical research funding faring during the COVID‐19 lockdown? Nat Med. 2020. 10.1038/d41591-020-00010-4 PubMed DOI

Harper L, Kalfa N, Beckers GMA, et al. The impact of COVID‐19 on research. J Pediatr Urol. 2020;16(5):715‐716. PubMed PMC

Alzheimer's Association Rapid Program in Dementia (RAPID) Funding Grant Program. https://www.alz.org/research/for_researchers/grants/types-of-grants/alzheimers-association-rapid-program-in-dementia

In: Coronavirus Job Retention Scheme: Supplementary Guidance for Research Organisations. UK: Department for Business, Energy & Industrial Strategy, UK Government; 2020. https://www.gov.uk/government/publications/coronavirus-job-retention-scheme-guidance-for-research-organisations/coronavirus-job-retention-scheme-supplementary-guidance-for-research-organisations

Common Features of Neurodegenerative Disease: Exploring the Brain‐Eye Connection and Beyond; 2021. https://adpd.kenes.com/common-features-of-neurodegenerative-disease-exploring-the-brain-eye-connection-and-beyond/

Alzheimer's Research UK Research Conference; 2021: https://www.alzheimersresearchuk.org/research/for-researchers/research-conference-2021/

Sarabipour S. Virtual conferences raise standards for accessibility and interactions. Elife. 2020;9:e62668. PubMed PMC

Bozelos PA, Vogels TP. Talking science, online. Nat Rev Neurosci. 2021;22(1):1‐2. PubMed PMC

Letter from Fédération des Centres Mémoires de France. https://www.centres‐memoire.fr/information‐covid‐19/

BrightFocus Foundation COVID‐19 Update. https://www.brightfocus.org/covid-19-update

Advice and support during COVID‐19: General advice and resources from Alzheimer associations. https://www.alzint.org/resource/advice-and-support-during-covid-19-general-advice-and-resources-from-alzheimer-associations/

de Erausquin GA, Snyder H, Carrillo M, et al. The chronic neuropsychiatric sequelae of COVID‐19: the need for a prospective study of viral impact on brain functioning. Alzheimers Dement. 2021;17(6):1056‐1065. PubMed PMC

International Brain Study: SARS‐CoV‐2 Impact on Behavior and Cognition. https://www.alz.org/research/for_researchers/partnerships/sars‐cov2‐global‐brain‐study